TrialTrials2016

A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial.

Annika Karch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.